Mahalumbay, Florentino L.

HRN: 12-38-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFTRIAXONE 1G (VIAL)
12/12/2023
12/18/2023
IV
2g
OD
Hypovolemic Shock Sec To AGE
Waiting Final Action 
12/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/13/2023
12/19/2023
IVT
500mg
Q8
Amoebiasis
Waiting Final Action 
12/16/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/16/2023
12/22/2023
IV
500mg
Q6
Amoebiasis
Waiting Final Action 
05/21/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/21/2024
05/28/2024
IV
2.25g
Q6
Septic Shock Secondary To UTI
Waiting Final Action 
05/28/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
05/28/2024
05/28/2024
IV
80
PRN For HD
IJ Prophylaxis
Waiting Final Action 
05/28/2024
MUPIROCIN 2%, 15G (TUBE)
05/28/2024
05/28/2024
TOPICAL
2%
PRN For HD
IJ Cath Prophylaxis
Waiting Final Action 
05/30/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
05/30/2024
05/30/2024
IV
80mg
Now
IJ Cath Prophylaxis
Waiting Final Action 
05/31/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
05/31/2024
05/31/2024
IV
40mg/ Port
STAT
IJ Cath Prophylaxis
Waiting Final Action 
06/04/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
06/04/2024
06/04/2024
IVTT
80mg
Stat
IJ Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: